Stefan Widensohler - St Jude Independent Director
Director
Mr. Stefan K. Widensohler was appointed as Independent Director of St. Jude Medical Inc. effective July 19 2013. Previously served as a Director of St.Jude Medical from 2001 to 2010. Since 1992 President and Chief Executive Officer of KRAUTH Medical Group which before 2012 was a European distributor of medical and surgical devices and services and which now invests in healthcare startup companies. Executive Vice President Global Sales and Marketing of Invatec SpA an Italian medical device company specializing in cardiology and peripheral vascular products from 1996 to 2010 and Vice President Global Sales after its acquisition by Medtronic Inc. from 2010 to 2012. Director of LDR Holdings Corporation a global medical device company since May 2006. since 2013.
| Age | 54 |
| Tenure | 11 years |
| Phone | 651 756-3301 |
| Web | www.sjm.com |
St Jude Management Efficiency
St Jude's management efficiency ratios could be used to measure how well St Jude manages its routine affairs as well as how well it operates its assets and liabilities.The company has 6.39 B in debt with debt to equity (D/E) ratio of 1.29, which is OK given its current industry classification. St Jude Medical has a current ratio of 1.89, which is typical for the industry and considered as normal. Debt can assist St Jude until it has trouble settling it off, either with new capital or with free cash flow. So, St Jude's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like St Jude Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for STJ to invest in growth at high rates of return. When we think about St Jude's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Sally Johnson | Pearson PLC ADR | 51 | |
| Joshua Lewis | Pearson PLC ADR | 53 | |
| Harish Manwani | Pearson PLC ADR | 64 | |
| John Pappajohn | MYnd Analytics | 89 | |
| Suzanne Wood | Relx PLC ADR | 60 | |
| Peter Unanue | MYnd Analytics | 50 | |
| John Stauch | Deluxe | 56 | |
| Marike Lels | Relx PLC ADR | 61 | |
| Ronald Baldwin | Deluxe | 72 | |
| Nick Luff | Relx PLC ADR | 49 | |
| Robert MacLeod | Relx PLC ADR | 56 | |
| Donald McGrath | Deluxe | 72 | |
| Carol Mills | Relx PLC ADR | 63 | |
| Neil Metviner | Deluxe | 59 | |
| Mary ODwyer | Deluxe | 58 | |
| Victoria Treyger | Deluxe | 50 | |
| Vivienne Cox | Pearson PLC ADR | 60 | |
| Elizabeth Corley | Pearson PLC ADR | 63 | |
| Robin Smith | MYnd Analytics | 53 | |
| Adrian Hennah | Relx PLC ADR | 60 | |
| Stephen Nachtsheim | Deluxe | 73 | |
Management Performance
| Return On Equity | 0.23 | |||
| Return On Asset | 0.0011 |
St Jude Medical Leadership Team
Elected by the shareholders, the St Jude's board of directors comprises two types of representatives: St Jude inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STJ. The board's role is to monitor St Jude's management team and ensure that shareholders' interests are well served. St Jude's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, St Jude's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Lamb, Managing Director, Executive Director | ||
| Baroness Wheatcroft, Non-Executive Independent Director | ||
| Ian Gascoigne, Managing Director, Executive Director | ||
| John Heinmiller, Executive VP | ||
| Tony Dunk, Director - Investor Relations | ||
| Denis Gestin, President of International Division | ||
| Craig Gentle, CFO | ||
| Stephan Widensohler, Independent Director | ||
| Donald Zurbay, CFO and VP of Fin. | ||
| Lisa Andrade, Chief Marketing Officer | ||
| Wendy Yarno, Independent Director | ||
| Iain Cornish, Senior Independent Non-Executive Director | ||
| Richard Devenuti, Independent Director | ||
| Sarah Bates, Non-Executive Chairman of the Board | ||
| Jeffrey Dallager, Vice President Corporate Controller | ||
| Joel Becker, President - Americas Division | ||
| Stuart Essig, Independent Director | ||
| Andrew Croft, CFO, Executive Director | ||
| Barbara Hill, Independent Director | ||
| David Bellamy, Chief Executive, Executive Director | ||
| Roger Yates, Independent Non-Executive Director | ||
| John Brown, Independent Presiding Director | ||
| Daniel Starks, Executive Chairman | ||
| Eric Fain, Group President - St. Jude Medical | ||
| Elizabeth Kelly, Company Secretary | ||
| Rachel Ellingson, Vice President - Corporate Relations | ||
| Mark Carlson, Vice President - Global Clinical Affairs, Chief Medical Officer | ||
| Paul Bae, Chief Marketing Officer, Vice President - Global Human Resources | ||
| Michael Rousseau, CEO and President COO and Director | ||
| Mark Murphy, CIO and VP of Information Technology | ||
| Scott Thome, Vice President - Global Operations and Supply Chain | ||
| Michael Rocca, Independent Director | ||
| Simon Jeffreys, Independent Non-Executive Director | ||
| Jeff Fecho, Vice President - Global Quality | ||
| Jason Zellers, Vice President General Counsel, Corporate Secretary | ||
| J Weigelt, Director - Investor Relations | ||
| David Dvorak, Director | ||
| Robert Gardner, Director of Investment Management | ||
| Stefan Widensohler, Independent Director |
STJ Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is St Jude a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | |||
| Return On Asset | 0.0011 | |||
| Profit Margin | 0 % | |||
| Operating Margin | 21.11 % | |||
| Current Valuation | 19.98 B | |||
| Shares Outstanding | 282.2 M | |||
| Shares Owned By Insiders | 2.44 % | |||
| Shares Owned By Institutions | 86.30 % | |||
| Number Of Shares Shorted | 8.18 M | |||
| Price To Earning | 35.37 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards St Jude in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, St Jude's short interest history, or implied volatility extrapolated from St Jude options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in STJ Stock
If you are still planning to invest in St Jude Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the St Jude's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |